biomarker discovery

NEW YORK (GenomeWeb) – Cancer Genetics today said that it will collaborate with a researcher at Keck Medicine of the University of Southern California to identify genomic markers of diffuse large B-cell lymphoma.

NEW YORK (GenomeWeb) – The National Institute of Neurological Disorders and Stroke will support research projects to discover and use biomarkers for Parkinson's disease, NINDS said in a new funding announcement on Monday.

NEW YORK (GenomeWeb) – Protea Biosciences Group today said that it has signed an agreement to collaborate with the University of Southampton to identify biomarkers that may indicate a risk of developing Alzheimer's disease.

NEW YORK (GenomeWeb) – Bioinformatics firm Berg today said that it will collaborate with researchers at the University of South Carolina in a search for lupus biomarkers.

NEW YORK (GenomeWeb News) – A non-profit organization called the National Biomarker Development Alliance has launched to develop standards and guidelines for supporting biomarker development and use, the NBDA said today.

NEW YORK (GenomeWeb News) — Exosome Diagnostics said today that it has entered into a collaboration agreement with Eli Lilly for biomarker discovery and validation using Exosome's EXO50 nucleic acid extraction kit.

NEW YORK (GenomeWeb News) – Bruker said today at the 12th annual meeting of the Human Proteome Organization in Yokohama, Japan, that it has launched a second-phase collaboration agreement with SISCAPA Assays Technologies to apply the SISCAPA immunoenrichment mass spec method to its MALDI-TOF inst

NEW YORK (GenomeWeb News) – The University of Manchester's Institute of Cancer Sciences said today that it will lead an international consortium that will use €6 million ($7.9 million) in funding to develop genetic biomarkers to identify patients who are at risk of developing long-term side effec

NEW YORK (GenomeWeb News) – The European Union plans to fund new research seeking to establish the clinical utility of epigenetic biomarkers for blood-based diseases under its Blueprint consortium program, a €30 million ($39.8 million) effort focused on advancing hematopoietic biomarkers.

NEW YORK (GenomeWeb News) – Ten institutes at the National Institutes of Health plan to provide $17.5 million in funding next year to support a network of as many as 14 consortia that will pursue clinica